"Hepatitis C treatment turned me around:" Psychological and behavioral transformation related to hepatitis C treatment

Drug and Alcohol Dependence

Volumn 153, Issue , 2015, Pages 66-71

  Batchelder, A W ^a,b   Peyser, D ^a,c   Nahvi, S ^a   Arnsten, J H ^a   Litwin, A H ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF SAN FRANCISCO   (United States)

^c RUTGERS UNIVERSITY   (United States)

Author keywords

Hepatitis C; Injection drug use; Internalized stigma; Methadone maintenance; Shame

Indexed keywords

METHADONE; NARCOTIC ANALGESIC AGENT;

ADULT; ARTICLE; ATTITUDE TO ILLNESS; BEHAVIOR CHANGE; CLINICAL ARTICLE; FEMALE; HEPATITIS C; HUMAN; INTERPERSONAL COMMUNICATION; MALE; MIDDLE AGED; OPIATE ADDICTION; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; PUBLIC HEALTH; SELF CARE; SELF CONCEPT; SEMI STRUCTURED INTERVIEW; SHAME; SOCIAL STIGMA; THEMATIC ANALYSIS; UNITED STATES; COMPLICATION; DRUG USE; OPIATE SUBSTITUTION TREATMENT; PSYCHOLOGY; STEREOTYPING; SUBSTANCE ABUSE; YOUNG ADULT;

HEPATITIS C VIRUS;

ADULT; ANALGESICS, OPIOID; DRUG USERS; FEMALE; HEPATITIS C; HUMANS; MALE; METHADONE; MIDDLE AGED; OPIATE SUBSTITUTION TREATMENT; SELF CARE; SHAME; STEREOTYPING; SUBSTANCE ABUSE, INTRAVENOUS; YOUNG ADULT;

EID: 84937639432     PISSN: 03768716     EISSN: 18790046     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2015.06.007     Document Type: Article

References (36)

1. Afdhal N.H., Zeuzem S., Schooley R.T., Thomas D.L., Ward J.W., Litwin A.H., Razavi H., Castera L., Poynard T., Muir A., Mehta S.H., Dee L., Graham C., Church D.R., Talal A.H., Sulkowski M.S., Jacobson I.M. The new paradigm of hepatitis C therapy: integration of oral therapies into best practices. J. Viral Hepat. 2013, 20:745-760. New Paradigm of HCV Therapy Meeting Participants.
2. Astone-Twerell J., Strauss S.M., Munoz-Plaza C. Stigma: Hepatits C and Drug Abuse 2006, National Development and Research Institute. The HCV Advocate Medical Writers' Circle, New York, NY.
3. Braun V., Clarke V. Using thematic analysis in psychology. Qual. Res. Psychol. 2006, 3:77-101.
4. Butt G. Stigma in the context of hepatitis C: concept analysis. J. Adv. Nurs. 2008, 62:712-724.
5. Center for Disease Control and Prevention, 2014. Available at: (accessed 10.03.15). http://www.cdc.gov/hepatitis/hcv/hcvfaq.htm.
6. Chen E.Y., North C.S., Fatunde O., Bernstein I., Salari S., Day B., Jain M.K. Knowledge and attitudes about hepatitis C virus (HCV) infection and its treatment in HCV mono-infected and HCV/HIV co-infected adults. J. Viral Hepat. 2013, 20:708-714.
7. Evon D.M., Golin C.E., Fried M.W., Keefe F.J. Chronic hepatitis C and antiviral treatment regimens: where can psychology contribute?. J. Consult. Clin. Psychol. 2013, 81:361-374.
8. Galindo L., Maginnis T., Wallace G., Hansen A., Sylvestre D. Education by peers is the key to success. Int. J. Drug Policy 2007, 18:411-416.
9. Glaser B.G., Strauss A.L. The Discovery of Grounded Theory: Strategies for Qualitative Research 1967, Aldine Publishing Company, Chicago.
10. Hagan H., Pouget E.R., Des Jarlais D.C., Lelutiu-Weinberger C. Meta-regression of hepatitis C virus infection in relation to time since onset of illicit drug injection: the influence of time and place. Am. J. Epidemiol. 2008, 168:1099-1109.
11. Harris M., Rhodes T. Hepatitis C treatment access and uptake for people who inject drugs: a review mapping the role of social factors. Harm Reduct. J. 2013, 10. 7-7517-10-7.
12. Heijnders M., Van Der Meij S. The fight against stigma: an overview of stigma-reduction strategies and interventions. Psychol. Health Med. 2006, 11:353-363.
13. Jauffret-Roustide M., Cohen J., Poisot-Martin I., Spire B., Gossop M., Carrieri M.P. Distributive sharing among HIV-HCV co-infected injecting drug users: the preventive role of trust in one's physician. AIDS Care 2012, 24:232-238. Manif 2000 Study Group.
14. Lekas H.M., Siegel K., Leider J. Felt and enacted stigma among HIV/HCV-coinfected adults: the impact of stigma layering. Qual. Health Res. 2011, 21:1205-1219.
15. Link B.G., Phelan J.C. Conceptualizing stigma. Annu. Rev. Sociol. 2001, 27:363-385.
16. Litwin A.H., Harris K.A., Nahvi S., Zamor P.J., Soloway I.J., Tenore P.L., Kaswan D., Gourevitch M.N., Arnsten J.H. Successful treatment of chronic hepatitis C with pegylated interferon in combination with ribavirin in a methadone maintenance treatment program. J. Subst. Abuse Treat. 2009, 37:32-40.
17. Litwin A.H., Soloway I., Gourevitch M.N. Integrating services for injection drug users infected with hepatitis C virus with methadone maintenance treatment: challenges and opportunities. Clin. Infect. Dis. 2005, 40(Suppl. 5):S339-S345.
18. Marinho R.T., Barreira D.P. Hepatitis C, stigma and cure. World J. Gastroenterol. 2013, 19:6703-6709.
19. Metts J., Carmichael L., Kokor W., Scharffenberg R. Hepatitis C: prevalence, transmission, screening, and prevention. FP Essent. 2014, 427:11-17.
20. Norman J., Walsh N.M., Mugavin J., Stoove M.A., Kelsall J., Austin K., Lintzeris N. The acceptability and feasibility of peer worker support role in community based HCV treatment for injecting drug users. Harm Reduct. J. 2008, 5. 8-7517-5-8.
21. Papadopoulos V., Gogou A., Mylopoulou T., Mimidis K. Should active injecting drug users receive treatment for chronic hepatitis C?. Arq. Gastroenterol. 2010, 47:238-241.
22. Paterson B.L., Backmund M., Hirsch G., Yim C. The depiction of stigmatization in research about hepatitis C. Int. J. Drug Policy 2007, 18:364-373.
23. Rance J., Treloar C. "We are people too": consumer participation and the potential transformation of therapeutic relations within drug treatment. Int. J. Drug Policy 2014, 26:30-36.
24. Rance J., Treloar C. 'Not just Methadone Tracy': transformations in service-user identity following the introduction of hepatitis C treatment into Australian opiate substitution settings. Addiction 2014, 109:452-459. ETHOS Study Group.
25. Roose R.J., Cockerham-Colas L., Soloway I., Batchelder A., Litwin A.H. Reducing barriers to hepatitis C treatment among drug users: an integrated hepatitis C peer education and support program. J. Health Care Poor Underserved 2014, 25:652-662.
26. Sgorbini M., O'Brien L., Jackson D. Living with hepatitis C and treatment: the personal experiences of patients. J. Clin. Nurs. 2009, 18:2282-2291.
27. Stein M.R., Soloway I.J., Jefferson K.S., Roose R.J., Arnsten J.H., Litwin A.H. Concurrent group treatment for hepatitis C: implementation and outcomes in a methadone maintenance treatment program. J. Subst. Abuse Treat. 2012, 43:424-432.
28. Swan D., Long J., Carr O., Flanagan J., Irish H., Keating S., Keaveney M., Lambert J., McCormick P.A., McKiernan S., Moloney J., Perry N., Cullen W. Barriers to and facilitators of hepatitis C testing, management, and treatment among current and former injecting drug users: a qualitative exploration. AIDS Patient Care STDS 2010, 24:753-762.
29. Treloar C., Newland J., Harris M., Deacon R., Maher L. A diagnosis of hepatitis C - insights from a study on patients' experiences. Aust. Fam. Physician 2010, 39:589-592.
30. Treloar C., Rance J., Backmund M. Understanding barriers to hepatitis C virus care and stigmatization from a social perspective. Clin. Infect. Dis. 2013, 57(Suppl. 2):S51-S55.
31. van de Laar T.J., Molenkamp R., van den Berg C., Schinkel J., Beld M.G., Prins M., Coutinho R.A., Bruisten S.M. Frequent HCV reinfection and superinfection in a cohort of injecting drug users in Amsterdam. J. Hepatol. 2009, 51:667-674.
32. Vogel D.L., Bitman R.L., Hammer J.H., Wade N.G. Is stigma internalized? The longitudinal impact of public stigma on self-stigma. J. Couns. Psychol. 2013, 60:311-316.
33. Wei F., Liu J., Liu F., Hu H., Ren H., Hu P. Interferon-based anti-viral therapy for hepatitis C virus infection after renal transplantation: an updated meta-analysis. PLoS One 2014, 9:e90611.
34. Woolhouse S., Cooper E., Pickard A. "It gives me a sense of belonging": providing integrated health care and treatment to people with HCV engaged in a psycho-educational support group. Int. J. Drug Policy 2013, 24:550-557.
35. Zickmund S., Ho E.Y., Masuda M., Ippolito L., LaBrecque D.R. "They treated me like a leper". Stigmatization and the quality of life of patients with hepatitis C. J. Gen. Intern. Med. 2003, 18:835-844.
36. Zickmund S.L., Campbell S.A., Tirado C.F., Zook C.L., Weinrieb R.M. Perceived barriers to hepatitis C therapy for patients receiving opioid agonist treatment. J. Addict. Med. 2012, 6:233-239.